Freshworks to Enter S&P SmallCap 600 on October 8
Freshworks will replace BioLife Solutions in the index as Repligen’s acquisition of BioLife nears completion, subject to final closing conditions.
Makkler Newsroom · Oct 6, 02:43 AM · 1 min read
Market open· · USD · Data may be delayed
Avg. target $204.50 (+23.6%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.